, p16
INK4a and p21 WAF1/Cip1 during breast cancer progression in a large patient cohort.
Methods and results
We conducted a retrospective study of 1080 patients with invasive ductal carcinoma, no special type, over an 11-year period. We performed immunohistochemical staining on tissue microarrays that included normal, benign hyperplasia, ductal carcinoma in situ and invasive ductal carcinoma tissue from each patient. Invasive ductal carcinomas showed higher expression of p14 ARF and p16
INK4a but lower expression of p21 WAF1/Cip1 than non-malignant tissues. There were significant correlations of normal, benign, preinvasive and malignant tissues with p14 ARF , p16
INK4a and p21 WAF1/Cip1 expression (P < 0.05). Univariate comparison showed a correlation between high p16
INK4a expression and poor survival (P = 0.000) and an increased risk of relapse (P = 0.000), whereas high p14 ARF expression correlated only with an increased risk of relapse (P = 0.038). Multivariate analysis showed p16
INK4a to be an important prognostic factor for overall survival (P = 0.011) and disease-free survival (P = 0.004), with p14 ARF also being a significant prognostic factor for disease-free survival (P = 0.043). Moreover, patients showing both high p16 INK4a expression and and high p14 ARF expression had an adjusted three-fold increased risk of disease recurrence (P < 0.05) and a two-fold increased risk of all-cause-related death (P < 0.05).
Conclusions
These finding suggest p16
INK4a expression and p14 ARF expression may play an important role in the progression of proliferative breast tissue to invasive cancer, and may be useful as prognostic factors.
